LDLuis Alberto Oliveira Dallan

Luis Alberto Oliveira Dallan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Luis Alberto Oliveira Dallan has a total of 205 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Off-Pump Versus On-Pump Coronary Artery Bypass Grafting in Prefrail and Frail Patients: 30-Day and 1-Year Outcomes From the FRAGILE Randomized Trial

    by Omar Asdrúbal Vilca Mejia, Bianca Meneghini, Fabiane Letícia de Freitas, Maurilio Onofre Deininger, Rodrigo Coelho Segalote, Felipe Cosentino, Alexandre Ciappina Hueb, Mauricio Landulfo Jorge Guerrieri, Fernando Faglioni Ribas, Fabiano Gonçalves Jucá, et al.

    BACKGROUND: Frailty is associated with worse outcomes after coronary artery bypass grafting (CABG). However, the comparative effectiveness of off-pump CABG (OPCAB) versus on-pump CABG (ONCAB) in prefrail and frail patients remains uncertain. METHODS: This multicenter, randomized, open-label trial enrolled patients ≥60 years of age classified as prefrail or frail, randomized 1:1, between January 2018 and December 2024. The primary outcome was a 30-day composite of death, myocardial infarction, stroke, renal failure, acute respiratory distress syndrome, or reoperation for bleeding. Secondary outcomes included ventilation time, intensive care unit and hospital stay, transfusion requirements, completeness of revascularization, surgical wound infection at 30 days, and neurocognitive function preoperatively and at 1 year. Analyses followed the intention-to-treat principle; relative risks with 95% CIs were estimated. RESULTS: A total of 508 patients were included (OPCAB, n=258; ONCAB, n=250; median age, 68 years [interquartile range, 65.0–73]; 30.5% female). The primary composite outcome occurred in 28 patients receiving OPCAB (10.9%) and 40 patients receiving ONCAB (16.0%; relative risk, 1.47 [95% CI, 0.94–2.31]; P =0.09). Surgical wound infection was more frequent with ONCAB (20 [8.0%] versus 9 [3.5%]; P =0.04). No significant differences were observed in neurocognitive or quality of life outcomes at 1 year. Estimated 1-year survival probabilities were 96.1% and 92.8% in the OPCAB and ONCAB groups, respectively ( P =0.099). CONCLUSIONS: In prefrail and frail patients undergoing CABG, OPCAB and ONCAB resulted in similar rates of the primary composite outcome. No significant differences between OPCAB and ONCAB were found in neurocognitive outcomes. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02338947.

  • Open Access

    Minimally invasive coronary artery bypass grafting (MINI-CABG): Protocol for a pilot randomized controlled trial comparing minimally invasive versus conventional coronary surgery

    by Luis Roberto Palma Dallan, Luiz Augusto Ferreira Lisboa, Omar Asdrubal Vilca Mejia, Antonio Francisco Neves Filho, Torsten Doenst, Oleksandr Babliak, Gustavo Alfredo Orellana Sampedro, Fabio Biscegli Jatene

    Introduction: Coronary artery bypass grafting (CABG) via sternotomy remains the standard of care for multivessel coronary disease. Minimally invasive cardiac surgery for coronary artery bypass grafting (MICS-CABG) is an evolving technique with the potential to reduce surgical trauma and promote faster recovery without compromising outcomes. This protocol describes a pilot randomized controlled trial comparing MICS-CABG and conventional CABG in multivessel patients in a high-volume tertiary center. Methods and analysis: This is a single-center, prospective, randomized controlled pilot trial. A total of 100 patients with multivessel coronary artery disease will be randomized (1:1) to undergo either conventional CABG via median sternotomy or MICS-CABG through a left anterior thoracotomy. The sample size of 100 patients (50 per group) was defined based on feasibility and statistical precision. This allows estimation of an expected 8% major adverse cardiovascular and cerebrovascular events (MACCE) rate with a 95% confidence interval half-width of ±5% in each group. These data will inform sample size calculations for a future phase III trial. The primary outcomes are safety and feasibility. Feasibility will be assessed by the successful completion of the planned minimally invasive coronary revascularization strategy. Safety will be evaluated through the occurrence of MACCE within 30 days postoperatively. Secondary outcomes include operative time, mechanical ventilation time, conversion rate to sternotomy, bleeding volume, atrial fibrillation, postoperative ICU and hospital length of stay, and patient-reported quality of life (EQ-5D-5L) 6 months postoperatively. The trial is ongoing at this moment. Ethics and dissemination: The protocol was approved by the Institutional Research Ethics Committee under que number CAAE: 54175921.8.0000.0068. Results will be disseminated through peer-reviewed publications and scientific conferences. Trial registration number: ClinicalTrials.gov NCT06794359 .

  • Open Access

    Guideline for Chronic Coronary Syndrome – 2025

    by Luiz A. Machado Cesar, Luis Henrique W. Gowdak, Ricardo Pavanello, João Fernando M. Ferreira, Bruno M. Mioto, Nilson T. Poppi, Caio Menezes M. de Mendonça, Adenalva Lima de Souza Beck, Adriana Soares Xavier de Brito, Alexandre Abizaid, et al.


  • Diretriz de Síndrome Coronariana Crônica – 2025

    by Luiz A. Machado Cesar, Luis Henrique W. Gowdak, Ricardo Pavanello, João Fernando M. Ferreira, Bruno M. Mioto, Nilson T. Poppi, Caio Menezes M. de Mendonça, Adenalva Lima de Souza Beck, Adriana Soares Xavier de Brito, Alexandre Abizaid, et al.


  • Open Access

    Is the Fate of the Internal Mammary Vein in CABG Similar to that of the Saphenous Vein?

    by Luis Roberto Palma Dallan, Luis Alberto Oliveira Dallan, Antonio Neves Filho, Omar Asdrubal Vilca Mejia, Luiz Augusto Ferreira Lisboa, Fabio B. Jatene

  • Open Access

    Resultados Imediatos após Múltiplos Enxertos Arteriais em Cirurgia de Revascularização Miocárdica no Estado de São Paulo: Estudo de Coorte

    by Raúl Armando Micalay Paredes, Gabrielle Barbosa Borgomoni, Anny Kátia Puchalski Micalay, José Carlos Arteaga Camacho, Luiz Augusto Ferreira Lisboa, Luís Alberto de Oliveira Dallan, Omar Asdrúbal Vilca Mejia

    Resumo Fundamento Os resultados a curto prazo após o uso de enxertos arteriais ainda suscitam questionamentos e dúvidas na sociedade médica. Objetivo Comparar os resultados imediatos de pacientes submetidos à cirurgia de revascularização do miocárdio com enxerto arterial único versus enxertos arteriais múltiplos. Métodos Estudo de coorte transversal no Registro Paulista de Cirurgia Cardiovascular II (REPLICCAR II). Os dados perioperatórios de 3122 pacientes foram agrupados pelo número de enxertos arteriais utilizados e seus desfechos foram comparados: reoperação, infecção profunda da [...] Resumo Fundamento Os resultados a curto prazo após o uso de enxertos arteriais ainda suscitam questionamentos e dúvidas na sociedade médica. Objetivo Comparar os resultados imediatos de pacientes submetidos à cirurgia de revascularização do miocárdio com enxerto arterial único versus enxertos arteriais múltiplos. Métodos Estudo de coorte transversal no Registro Paulista de Cirurgia Cardiovascular II (REPLICCAR II). Os dados perioperatórios de 3122 pacientes foram agrupados pelo número de enxertos arteriais utilizados e seus desfechos foram comparados: reoperação, infecção profunda da


  • Quality improvement program in Latin America decreases mortality after cardiac surgery: a before-after intervention study

    by Omar Asdrúbal Vilca Mejia, Gabrielle Barbosa Borgomoni, Bruno Mahler Mioto, Tarso Augusto Duenhas Accorsi, Eduardo Gomes Lima, Alexandre de Matos Soeiro, Felipe Gallego Lima, Carlos Manuel de Almeida Brandão, Pablo Maria Alberto Pomerantzeff, Luís Alberto Oliveira Dallan, et al.

    The current challenge of cardiac surgery (CS) is to improve outcomes in adverse scenarios. The aim of this study was to assess the impact of a quality improvement program (QIP) on hospital mortality in the largest CS center in Latin America. Patients were divided into two groups: before (Jan 2013-Dec 2015, n = 3534) and after establishment of the QIP (Jan 2017-Dec 2019, n = 3544). The QIP consisted of the implementation of 10 central initiatives during 2016. The procedures evaluated were isolated coronary artery bypass grafting surgery (CABG), mitral valve surgery, aortic valve surgery, combined mitral and aortic valve surgery, and CABG associated with heart valve surgery. Propensity Score Matching (PSM) was used to adjust for inequality in patients' preoperative characteristics before and after the implementation of QIP. A multivariate logistic regression model was built to predict hospital mortality and validated using discrimination and calibration metrics. The PMS paired two groups using 5 variables, obtaining 858 patients operated before (non-QIP) and 858 patients operated after the implementation of the QIP. When comparing the QIP versus Non-QIP group, there was a shorter length of stay in all phases of hospitalization. In addition, the patients evolved with less anemia (P = 0.001), use of intra-aortic balloon pump (P = 0.003), atrial fibrillation (P = 0.001), acute kidney injury (P < 0.001), cardiogenic shock (P = 0.011), sepsis (P = 0.046), and hospital mortality (P = 0.001). In the multiple model, among the predictors of hospital mortality, the lack of QIP increased the chances of mortality by 2.09 times. The implementation of a first CS QIP in Latin America was associated with a reduction in length of hospital stay, complications and mortality after the cardiac surgeries analyzed.


  • Transit‐time flow measurement parameters after protamine infusion in CABG surgeries

    by Luis Alberto O. Dallan, Luiz Augusto F. Lisboa, Omar A. V. Mejia, Fernando Platania, Renan de Carvalho Rodrigues, Luis Augusto P. Dallan, Fabio B. Jatene

    Objective The objective of this study is to evaluate protamine sulfate effects on graft's blood flow by comparing transit-time flow measurement (TTFM) values before and after protamine administration. Methods This is an observational study with data collected between years 2018 and 2020. Immediate graft patency was evaluated using TTFM. Only patients with TTFM parameters registered before and after protamine infusion were included. The main three parameters studied were: mean graft flow (MGF), pulsatility index (PI), and diastolic flow (DF). In the first analysis, all conduits were evaluated regardless of the surgical technique used. In a second analysis, on-pump and off-pump groups were compared. Evaluated grafts were left internal thoracic artery, saphenous vein graft (SVG), radial artery, and right internal thoracic artery. Since SVG was numerically the most used graft, an exclusive analysis was created. Results Our study included 575 patients, resulting in a total of 1686 grafts, mean 2.93 grafts/patient. Off-pump surgery was performed in 158 patients. Before protamine infusion, inadequate TTFM parameters were observed in 3.8% of grafts. Overall, after protamine administration, MGF decreased in all grafts, but its reduction was not statistically significant. PI values increased in the SVG and DF values reduced in LIMA grafts. SVG group analysis showed that after protamine PI values were higher in OM1 and RCA. DF values increased in RCA. The comparison between off and on-pump surgeries, showed that in off-pump cases TTFM measures did not present statistically significant differences. Conclusion Significant variations were observed in TTFM values before and after protamine administration. Although different, those values remained within the normal reference ranges. We recommend that flow measurement should be performed before protamine infusion.


  • Open Access

    Adherence to the cardiac surgery checklist decreased mortality at a teaching hospital: A retrospective cohort study

    by Omar Asdrúbal Vilca Mejia, Frederico Carlos Cordeiro de Mendonça, Lucimar Aparecida Barrense Nogueira Sampaio, Filomena Regina Barbosa Gomes Galas, Mauricio Franklin Pontes, Luiz Fernando Caneo, Luís Roberto Palma Dallan, Luiz Augusto Ferreira Lisboa, João Fernando Monteiro Ferreira, Luís Alberto de Oliveira Dallan, et al.


  • A benchmark in the isolated tricuspid valve surgery is necessary

    by Luís A O Dallan, Luiz Augusto Ferreira Lisboa, Luís Roberto P Dallan, Fabio B Jatene

    Advances in surgical techniques, enabling correction of regurgitation, and preserving the tricuspid valve, are also factors that encourage early surgical indication and improve long-term outcomes.